![]() Gyre Therapeutics Gyre Therapeutics (formerly known as Catalyst Biosciences) is a drug R&D company creating catalytic biopharmaceutical products based on engineered human proteases. | ![]() Rexgenero Rexgenero is a regenerative medicine company developing cell-based therapeutics for the treatment of critical limb ischemia. | ||||
Founding Date | Founding Date 2018 | Founding Date 2003 | Founding Date 2015 | Founding Date 2020 | Founding Date 2011 |
Type | Type Private | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations San Francisco, US HQ | Locations South San Francisco, US HQ | Locations London, GB HQ Sevilla, ES Brighton, GB | Locations Boston, US HQ | Locations Amiens, FR HQ |
Employees | Employees 7 | Employees 3462% increase | Employees 910% decrease | Employees 552% decrease | Employees 19 |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 30m | Total funding raised N/A | Total funding raised $ 20m | Total funding raised N/A |

Gyre Therapeutics (formerly known as Catalyst Biosciences) is a drug R&D company creating catalytic biopharmaceutical products based on engineered human proteases.
View company
Rexgenero is a regenerative medicine company developing cell-based therapeutics for the treatment of critical limb ischemia.
View companyGentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs).
View companySamabriva is a biotechnology company specializing in the development of biotherapeutics.
View company